This site is intended for healthcare professionals only
LoginRegister
Kerala Blocks 17 Faulty Medicines Including Rabeprazole, Ciprofloxacin After Counterfeit SeizurePunjab Govt Sets Up Advisory Council, Warns Zero Tolerance on Spurious Drugs
Eli Lilly Donanemab secures CDSCO nod for early symptomatic Alzheimers DiseaseEli Lilly Donanemab secures CDSCO nod for early symptomatic Alzheimer's Disease
Hetero appoints Kshitiz Gadodia to Global Team as President - Finance & AccountsHetero appoints Kshitiz Gadodia to Global Team as President - Finance & Accounts
Gilead single tablet regimen of Bictegravir, Lenacapavir for HIV-1 meets primary endpoint in Phase 3 trialGilead single tablet regimen of Bictegravir, Lenacapavir for HIV-1 meets primary endpoint in Phase 3...
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreJnJ to acquire Halda Therapeutics for USD 3.05 billion
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamCDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof Cream 1% for...
Counterfeit Drug Racket Using Lupin Brand Busted in Puducherry, FIR FiledDanish Lab Chief Held for Allegedly Supplying Fake Amoxycillin, Cefixime Under SVR Healthcare's Name
Delhi pharma firm owner caught in drug trafficking case in JammuHimachal Pharma Firm Partner Arrested for Fake Levocetirizine, Pregabalin Production
Pfizer cuts BioNTech stake by 54.7 percentPfizer cuts BioNTech stake by 54.7 percent
Intas Pharma appoints Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing LaboratoryIntas Pharma appoints Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing...
Biocon to make Biocon Biologics a wholly owned armBiocon expects 50 percent drop in costs for developing complex biosimilars: Top executive
Novartis declares positive results from phase III study for new malaria treatmentNovartis declares positive results from phase III study for new malaria treatment
X